Morgan Stanley’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.76M Buy
323,606
+36,481
+13% +$1.18M ﹤0.01% 3586
2025
Q4
$9.97M Buy
287,125
+17,921
+7% +$633K ﹤0.01% 3620
2025
Q3
$9.78M Buy
269,204
+31,325
+13% +$1.06M ﹤0.01% 3572
2025
Q2
$7.46M Buy
237,879
+64,018
+37% +$1.99M ﹤0.01% 3719
2025
Q1
$5.16M Buy
173,861
+43,220
+33% +$1.3M ﹤0.01% 3898
2024
Q4
$3.85M Sell
130,641
-274,184
-68% -$8.67M ﹤0.01% 4214
2024
Q3
$12.6M Sell
404,825
-464,039
-53% -$16.9M ﹤0.01% 3248
2024
Q2
$29.4M Buy
868,864
+67,590
+8% +$3.45M ﹤0.01% 2251
2024
Q1
$52.1M Sell
801,274
-1,032,852
-56% -$70.9M ﹤0.01% 1722
2023
Q4
$125M Buy
1,834,126
+873,038
+91% +$45.4M 0.01% 1503
2023
Q3
$49.9M Buy
961,088
+148,466
+18% +$8.79M 0.01% 1583
2023
Q2
$48.7M Buy
812,622
+16,131
+2% +$921K ﹤0.01% 1592
2023
Q1
$39.4M Buy
796,491
+441,769
+125% +$24.8M ﹤0.01% 1765
2022
Q4
$20.2M Buy
354,722
+204,972
+137% +$11.5M ﹤0.01% 2333
2022
Q3
$7.03M Buy
149,750
+126,403
+541% +$6.02M ﹤0.01% 3342
2022
Q2
$871K Buy
23,347
+20,995
+893% +$682K ﹤0.01% 5099
2022
Q1
$70K Buy
2,352
+947
+67% +$23.9K ﹤0.01% 6523
2021
Q4
$48K Sell
1,405
-916
-39% -$33.2K ﹤0.01% 6832
2021
Q3
$86K Buy
2,321
+2,301
+11,505% +$77.7K ﹤0.01% 6455
2021
Q2
$1K Sell
20
-15,187
-100% -$586K ﹤0.01% 7614
2021
Q1
$648K Buy
+15,207
New +$677K ﹤0.01% 5010

Other funds holding IMCR